Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 2 |
GO:0016020 | membrane | 2 | 12 |
GO:0031090 | organelle membrane | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: Q4Q1L1
Term | Name | Level | Count |
---|---|---|---|
GO:0006457 | protein folding | 2 | 2 |
GO:0006458 | 'de novo' protein folding | 3 | 2 |
GO:0006508 | proteolysis | 4 | 2 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0006950 | response to stress | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009057 | macromolecule catabolic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010033 | response to organic substance | 3 | 2 |
GO:0010243 | response to organonitrogen compound | 4 | 2 |
GO:0010498 | proteasomal protein catabolic process | 5 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 2 |
GO:0030163 | protein catabolic process | 4 | 2 |
GO:0030433 | ubiquitin-dependent ERAD pathway | 6 | 2 |
GO:0033554 | cellular response to stress | 3 | 2 |
GO:0034976 | response to endoplasmic reticulum stress | 4 | 2 |
GO:0035966 | response to topologically incorrect protein | 3 | 2 |
GO:0035967 | cellular response to topologically incorrect protein | 4 | 2 |
GO:0036503 | ERAD pathway | 5 | 2 |
GO:0042221 | response to chemical | 2 | 2 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 2 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0051084 | 'de novo' post-translational protein folding | 4 | 2 |
GO:0051085 | chaperone cofactor-dependent protein refolding | 4 | 2 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 2 |
GO:0051788 | response to misfolded protein | 4 | 2 |
GO:0061077 | chaperone-mediated protein folding | 3 | 2 |
GO:0070887 | cellular response to chemical stimulus | 3 | 2 |
GO:0071218 | cellular response to misfolded protein | 5 | 2 |
GO:0071310 | cellular response to organic substance | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
GO:1901698 | response to nitrogen compound | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 2 |
GO:0005515 | protein binding | 2 | 2 |
GO:0030544 | Hsp70 protein binding | 4 | 2 |
GO:0031072 | heat shock protein binding | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 172 | 176 | PF00656 | 0.485 |
CLV_C14_Caspase3-7 | 247 | 251 | PF00656 | 0.354 |
CLV_C14_Caspase3-7 | 29 | 33 | PF00656 | 0.387 |
CLV_C14_Caspase3-7 | 69 | 73 | PF00656 | 0.457 |
CLV_NRD_NRD_1 | 232 | 234 | PF00675 | 0.462 |
CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.547 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.531 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.547 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.249 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.495 |
CLV_PCSK_PC1ET2_1 | 75 | 77 | PF00082 | 0.260 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.471 |
CLV_PCSK_SKI1_1 | 282 | 286 | PF00082 | 0.616 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.320 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.683 |
DOC_ANK_TNKS_1 | 80 | 87 | PF00023 | 0.640 |
DOC_CKS1_1 | 221 | 226 | PF01111 | 0.354 |
DOC_CYCLIN_yClb1_LxF_4 | 149 | 155 | PF00134 | 0.554 |
DOC_CYCLIN_yCln2_LP_2 | 153 | 159 | PF00134 | 0.421 |
DOC_MAPK_gen_1 | 232 | 238 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 232 | 240 | PF00069 | 0.331 |
DOC_PP2B_LxvP_1 | 153 | 156 | PF13499 | 0.421 |
DOC_PP2B_LxvP_1 | 216 | 219 | PF13499 | 0.298 |
DOC_USP7_MATH_1 | 191 | 195 | PF00917 | 0.357 |
DOC_USP7_MATH_1 | 224 | 228 | PF00917 | 0.354 |
DOC_USP7_MATH_1 | 95 | 99 | PF00917 | 0.732 |
DOC_USP7_UBL2_3 | 36 | 40 | PF12436 | 0.454 |
DOC_USP7_UBL2_3 | 41 | 45 | PF12436 | 0.442 |
DOC_USP7_UBL2_3 | 50 | 54 | PF12436 | 0.460 |
DOC_WW_Pin1_4 | 220 | 225 | PF00397 | 0.354 |
LIG_14-3-3_CanoR_1 | 209 | 214 | PF00244 | 0.239 |
LIG_14-3-3_CanoR_1 | 96 | 104 | PF00244 | 0.756 |
LIG_BRCT_BRCA1_1 | 193 | 197 | PF00533 | 0.354 |
LIG_DLG_GKlike_1 | 209 | 216 | PF00625 | 0.335 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.294 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.632 |
LIG_FHA_2 | 170 | 176 | PF00498 | 0.488 |
LIG_FHA_2 | 245 | 251 | PF00498 | 0.298 |
LIG_FHA_2 | 3 | 9 | PF00498 | 0.590 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.460 |
LIG_GBD_Chelix_1 | 157 | 165 | PF00786 | 0.339 |
LIG_LIR_Gen_1 | 114 | 121 | PF02991 | 0.611 |
LIG_LIR_Gen_1 | 168 | 179 | PF02991 | 0.635 |
LIG_LIR_Gen_1 | 235 | 245 | PF02991 | 0.299 |
LIG_LIR_Gen_1 | 277 | 285 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 114 | 119 | PF02991 | 0.588 |
LIG_LIR_Nem_3 | 168 | 174 | PF02991 | 0.616 |
LIG_LIR_Nem_3 | 18 | 24 | PF02991 | 0.469 |
LIG_LIR_Nem_3 | 277 | 281 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.449 |
LIG_Pex14_2 | 115 | 119 | PF04695 | 0.590 |
LIG_PTB_Apo_2 | 175 | 182 | PF02174 | 0.475 |
LIG_SH2_CRK | 21 | 25 | PF00017 | 0.449 |
LIG_SH2_CRK | 221 | 225 | PF00017 | 0.354 |
LIG_SH2_NCK_1 | 171 | 175 | PF00017 | 0.511 |
LIG_SH2_STAT3 | 12 | 15 | PF00017 | 0.610 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.596 |
LIG_SH2_STAT5 | 171 | 174 | PF00017 | 0.507 |
LIG_SH2_STAT5 | 221 | 224 | PF00017 | 0.239 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.241 |
LIG_SUMO_SIM_par_1 | 22 | 29 | PF11976 | 0.488 |
MOD_CDK_SPK_2 | 220 | 225 | PF00069 | 0.298 |
MOD_CK1_1 | 169 | 175 | PF00069 | 0.498 |
MOD_CK1_1 | 71 | 77 | PF00069 | 0.496 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.335 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.609 |
MOD_Cter_Amidation | 252 | 255 | PF01082 | 0.535 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.412 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.457 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.396 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.263 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.334 |
MOD_GSK3_1 | 244 | 251 | PF00069 | 0.341 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.460 |
MOD_N-GLC_1 | 15 | 20 | PF02516 | 0.356 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.304 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.494 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.341 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.488 |
MOD_PIKK_1 | 197 | 203 | PF00454 | 0.341 |
MOD_PKA_2 | 208 | 214 | PF00069 | 0.239 |
MOD_PKA_2 | 224 | 230 | PF00069 | 0.239 |
MOD_PKA_2 | 248 | 254 | PF00069 | 0.289 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.717 |
MOD_Plk_4 | 209 | 215 | PF00069 | 0.309 |
MOD_ProDKin_1 | 220 | 226 | PF00069 | 0.354 |
MOD_SUMO_rev_2 | 235 | 245 | PF00179 | 0.335 |
TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.507 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.449 |
TRG_ENDOCYTIC_2 | 237 | 240 | PF00928 | 0.292 |
TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.314 |
TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.449 |
TRG_ER_diArg_1 | 105 | 108 | PF00400 | 0.746 |
TRG_ER_diArg_1 | 263 | 266 | PF00400 | 0.250 |
TRG_ER_diArg_1 | 281 | 283 | PF00400 | 0.343 |
TRG_Pf-PMV_PEXEL_1 | 76 | 80 | PF00026 | 0.260 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7P9 | Leptomonas seymouri | 67% | 99% |
A0A0S4JTE9 | Bodo saltans | 41% | 100% |
A0A1X0P7N5 | Trypanosomatidae | 53% | 100% |
A0A3Q8IH76 | Leishmania donovani | 98% | 100% |
A0A3R7LNU2 | Trypanosoma rangeli | 49% | 100% |
A4HP79 | Leishmania braziliensis | 86% | 100% |
A4IDI4 | Leishmania infantum | 98% | 100% |
D0A375 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9ASY7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
O13633 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 71% |
Q17438 | Caenorhabditis elegans | 30% | 71% |
Q58DR2 | Bos taurus | 30% | 77% |
Q6G1F8 | Bartonella quintana (strain Toulouse) | 28% | 75% |
Q7NBW0 | Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2)) | 31% | 73% |
Q7ZXQ8 | Xenopus laevis | 33% | 77% |
Q98PI9 | Mycoplasmopsis pulmonis (strain UAB CTIP) | 27% | 76% |
Q9NXW2 | Homo sapiens | 29% | 76% |
Q9QYI4 | Mus musculus | 29% | 76% |
V5BGE9 | Trypanosoma cruzi | 49% | 100% |